CACLP

CACLP TALKS | 🌏 What does it take to succeed in Southeast Asia’s rapidly evolving IVD market?

In this interview, Prof. Leslie Lam, shares his perspectives on the opportunities and challenges across a region of more than 680 million people.

While Southeast Asian countries face different healthcare realities, common challenges remain, including the lack of standardization and a shortage of skilled laboratory professionals.

📺 Watch the full interview https://youtu.be/wkiKHZGa1Ew?si=YOkc5BvDm9Ly0wbo

Talk with Prof. Leslie Lam at CACLP 2026 From the diverse healthcare needs of Southeast Asia’s 680 million p...

VIEW | Lateral flow assays ( ) remain a cornerstone of point-of-care diagnostics, but challenges in sensitivity and signal amplification continue to limit their performance.

This review explores how 2D materials can transform LFAs by serving as high-contrast signal reporters, biomolecule-loading scaffolds, catalytic amplifiers, and signal-conversion substrates. The authors also highlight emerging opportunities, from 2D material-functionalized membranes to next-generation materials with unique sensing capabilities.

For further info, please view 👉🏻 https://onlinelibrary.wiley.com/doi/epdf/10.1002/VIW.20260002

Industry | In Vitro Diagnostic Industry in China - Instruments and Reagents XIV——

It is foreseeable that development trend of Blood typing reagent technologies is mainly reflected by improvement of Blood typing accuracy, increase in Blood typing efficiency and reduction of test time; improvement of Blood typing sensitivity and prevention of missed test; evaluation of antibody titer determination and other aspects.

For further information 🔗 https://en.caclp.com/industry-news/3933.html

#𝐛𝐥𝐨𝐨𝐝𝐭𝐞𝐬𝐭

The 24th China International In Vitro Diagnostics by CACLP will officially take place 19-21 March 2027 at the Nanjing International Expo Center in , Jiangsu Province, China.

Nanjing offers extensive opportunities for business collaboration and market expansion. The city is home to leading universities, research institutes, innovation platforms, and a strong healthcare ecosystem including 41 top-tier hospitals, while Jiangsu Province hosts a total 123 top-tier hospitals.

Supported by a highly developed high-speed rail network, international airport, modern metro system, and strong regional economic influence, Nanjing provides efficient access to industry resources, clinical partnerships, talent, and global business opportunities.

For full press release, please click https://en.caclp.com/press-release/3931.html

CACLP TALKS | 🎙️As molecular diagnostics continues to evolve rapidly, is emerging as a key technology shaping the future of precision medicine.

In this interview, Prof. Vittorio Sambri shares his insights on the future of molecular diagnostics and discusses why NGS could become the next major direction beyond multiplex PCR.

For full interview 👉🏻 https://youtu.be/wScz1PNEdwc?si=mR5o-axMwefgwsT9

Talk with Prof. Vittorio Sambri at CACLP 2026 “The era of multiplex PCR may come to an end within the next five y...

VIEW | 🧫 New research highlights the growing potential of nonthermal plasma technology in combating bacterial infections and biofilm formation on medical devices, one of the leading causes of implant failure and healthcare-associated complications.

The review explores how plasma-based approaches, including plasma surface modification , plasma-activated liquids , and direct NTP treatments, can enhance antimicrobial activity and improve medical device decontamination.

For full research 👉🏻 https://onlinelibrary.wiley.com/doi/epdf/10.1002/VIW.20260018

CACLP TALKS | 🎥 is gold, is the tool, and laboratory professionals are the bridge.

In this exclusive interview, Prof. Sergio Bernardini discusses the early-stage application of AI in laboratory medicine and why laboratorians must become key drivers of change.

From breaking data silos to transforming laboratory medicine into a more proactive force in healthcare, Professor Bernardini shares his vision for the future of diagnostics.

For the full interview video https://youtu.be/Z8qGKHnAMWw?si=nb0FAWf7JOJ2jZN6

Talk with Prof. Sergio Bernardini at CACLP 2026 “Data is gold, AI is the tool, and laboratory professionals are the...

Industry | In Vitro Diagnostic Industry in China - Instruments and Reagents XIII——

At present, MGT-based blood group test card has been used extensively in the field of blood typing, and MGT boasts of easy operation, high sensitivity, accurate results that can be saved and other strengthens, which allowed it to become method recommended by American Association of Blood Banks (AABB), technique recognized by FDA and internationally recognized blood group analysis test technique.

For further information, please view: https://en.caclp.com/industry-news/3922.html

Business | China’s industry continues to accelerate strategic collaborations last week

🧬 Canhelp Genomics Partners with Eurobio Scientific to Expand European Markets
🔬 Agilent and Oebiotech Establish Strategic Partnership to Advance Quality Standards in Multi-Omics Services
👩‍⚕️ WONDFO and the Third Affiliated Hospital of Guangzhou Medical University Launch Preeclampsia Screening and Prevention Initiative
🤝 Maccura and Wellgrow Technology Join Forces to Build Smart Laboratory Ecosystem

For more details, view🔗 https://en.caclp.com/industry-news/3920.html

CACLP TALKS | 🎙️ Nearly 70% of Africa’s population still lacks access to diagnostic services, despite the continent carrying 24% of the global disease burden.

In this interview, Prof. Rajiv Erasmus discusses the urgent challenges facing laboratory medicine in Africa, from limited funding and infrastructure to talent migration, and how is beginning to reshape healthcare accessibility across the continent.

Prof. Erasmus also highlights the importance of global collaboration and invites Chinese companies to support the development of a sustainable healthcare industry, bringing diagnostic solutions closer to local communities.

For full interview🔗 https://youtu.be/8tDAYAY5xSc?si=2d5hUcUGpvmwHNZO

Talk with Prof. Rajiv Erasmus at CACLP 2026 Nearly 70% of the population in Africa still lacks access to diagnostic services. While the continent carries 24% of the global disease burden, it accounts f...